<?xml version="1.0" encoding="UTF-8"?><!-- generator="podbean/5.5" -->
<rss version="2.0"
     xmlns:content="http://purl.org/rss/1.0/modules/content/"
     xmlns:wfw="http://wellformedweb.org/CommentAPI/"
     xmlns:dc="http://purl.org/dc/elements/1.1/"
     xmlns:atom="http://www.w3.org/2005/Atom"
     xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd"
     xmlns:googleplay="http://www.google.com/schemas/play-podcasts/1.0"
     xmlns:spotify="http://www.spotify.com/ns/rss"
     xmlns:podcast="https://podcastindex.org/namespace/1.0"
    xmlns:media="http://search.yahoo.com/mrss/">

<channel>
    <title>CancerSpeak: An American Cancer Society Journals Podcast</title>
    <atom:link href="https://feed.podbean.com/cancerspeak/feed.xml" rel="self" type="application/rss+xml"/>
    <link>https://cancerspeak.podbean.com</link>
    <description><![CDATA[<p>For more than 75 years, the American Cancer Society (ACS) has published some of the most respected peer-reviewed journals in oncology.</p>
<p>CancerSpeak, the official podcast of the ACS Journals, brings this legacy to life through conversations with experts in clinical oncology and related disciplines, connecting listeners with the research and perspectives featured across its titles.</p>
<p>Originally launched in 2023 to highlight research from <em>Cancer</em>, the podcast is expanding to feature work across the full ACS journals portfolio, including <em>CA: A Cancer Journal for Clinicians</em>, <em>Cancer Cytopathology</em>, and <em>Pediatric, Adolescent &amp; Young Adult Cancer</em>.</p>
<p>Each episode examines timely topics with leading experts in their fields, including recent studies, new clinical guidance, and major highlights from annual meetings. When possible, episodes incorporate the patient experience, highlighting the real-world impact of the work we publish.</p>]]></description>
    <pubDate>Wed, 07 Jan 2026 15:39:52 -0400</pubDate>
    <generator>https://podbean.com/?v=5.5</generator>
    <language>en</language>
        <copyright>Copyright 2023. All rights reserved.</copyright>
    <category>Health &amp; Fitness:Medicine</category>
    <ttl>1440</ttl>
    <itunes:type>episodic</itunes:type>
          <itunes:summary>Introducing CancerSpeak, the official podcast of Cancer, a journal of the American Cancer Society. CancerSpeak is dedicated to bringing the best of science to the broadest audiences, offering the latest research, real-life stories, and expert perspectives from the field of oncology.</itunes:summary>
        <itunes:author>ACS Journal Cancer</itunes:author>
	<itunes:category text="Health &amp; Fitness">
		<itunes:category text="Medicine" />
	</itunes:category>
<itunes:category text="Science" />
    <itunes:owner>
        <itunes:name>ACS Journal Cancer</itunes:name>
            </itunes:owner>
    	<itunes:block>No</itunes:block>
	<itunes:explicit>false</itunes:explicit>
	<itunes:new-feed-url>https://feed.podbean.com/cancerspeak/feed.xml</itunes:new-feed-url>
    <itunes:image href="https://pbcdn1.podbean.com/imglogo/image-logo/14027812/CancerSpeak_logo_7_8ur48.png" />
    <image>
        <url>https://pbcdn1.podbean.com/imglogo/image-logo/14027812/CancerSpeak_logo_7_8ur48.png</url>
        <title>CancerSpeak: An American Cancer Society Journals Podcast</title>
        <link>https://cancerspeak.podbean.com</link>
        <width>144</width>
        <height>144</height>
    </image>
    <item>
        <title>Low-Grade Gliomas: Evolving Approaches to Care</title>
        <itunes:title>Low-Grade Gliomas: Evolving Approaches to Care</itunes:title>
        <link>https://cancerspeak.podbean.com/e/low-grade-gliomas-evolving-approaches-to-care/</link>
                    <comments>https://cancerspeak.podbean.com/e/low-grade-gliomas-evolving-approaches-to-care/#comments</comments>        <pubDate>Wed, 07 Jan 2026 15:39:52 -0400</pubDate>
        <guid isPermaLink="false">cancerspeak.podbean.com/3e5d334b-95e0-3030-9ca6-fcee9f6bb557</guid>
                                    <description><![CDATA[<p>Dr. Priya Kumthekar, Neuro-Oncology Section Editor for CANCER, and Dr. Helen Shih, Radiation Oncology Section Editor for CANCER, discuss the current treatment landscape for low-grade gliomas with a focus on the evolving role of isocitrate dehydrogenase (IDH) inhibitors. Drawing on findings from the INDIGO trial, they reflect on how recent evidence has informed ongoing discussions around the use of IDH inhibitors, alongside their perspectives on treatment planning and real-world clinical considerations. The conversation also emphasizes the importance of engaging patients in shared decision making throughout the course of care. </p>
<p>Drs. Kumthekar and Shih invite investigators in neuro-oncology, radiation oncology, and related disciplines to consider submitting their research to CANCER. Their closing remarks highlight the journal’s global reach, supportive editorial staff, and connection to the mission of the American Cancer Society. </p>
<p>Learn more about submitting your work to CANCER: <a href='https://acsjournals.onlinelibrary.wiley.com/journal/10970142/homepage/why-submit'>https://acsjournals.onlinelibrary.wiley.com/journal/10970142/homepage/why-submit</a>  </p>
<p>Original music by J.Gilman. </p>
<p>Follow CANCER on social media: 
<a href='https://x.com/JournalCancer'>x.com/JournalCancer</a> 
<a href='https://www.instagram.com/acsjournalcancer'>instagram.com/acsjournalcancer</a> 
<a href='https://www.linkedin.com/company/95674648/admin/dashboard/'>linkedin.com/company/acs-journals</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Dr. Priya Kumthekar, Neuro-Oncology Section Editor for CANCER, and Dr. Helen Shih, Radiation Oncology Section Editor for CANCER, discuss the current treatment landscape for low-grade gliomas with a focus on the evolving role of isocitrate dehydrogenase (IDH) inhibitors. Drawing on findings from the INDIGO trial, they reflect on how recent evidence has informed ongoing discussions around the use of IDH inhibitors, alongside their perspectives on treatment planning and real-world clinical considerations. The conversation also emphasizes the importance of engaging patients in shared decision making throughout the course of care. </p>
<p>Drs. Kumthekar and Shih invite investigators in neuro-oncology, radiation oncology, and related disciplines to consider submitting their research to CANCER. Their closing remarks highlight the journal’s global reach, supportive editorial staff, and connection to the mission of the American Cancer Society. </p>
<p>Learn more about submitting your work to CANCER: <a href='https://acsjournals.onlinelibrary.wiley.com/journal/10970142/homepage/why-submit'>https://acsjournals.onlinelibrary.wiley.com/journal/10970142/homepage/why-submit</a>  </p>
<p>Original music by J.Gilman. </p>
<p>Follow CANCER on social media: <br>
<a href='https://x.com/JournalCancer'>x.com/JournalCancer</a> <br>
<a href='https://www.instagram.com/acsjournalcancer'>instagram.com/acsjournalcancer</a> <br>
<a href='https://www.linkedin.com/company/95674648/admin/dashboard/'>linkedin.com/company/acs-journals</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ycjahhkenfjkiazy/Kumthekar_Shih_podcast_v2bvzhz.mp3" length="22463286" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Dr. Priya Kumthekar, Neuro-Oncology Section Editor for CANCER, and Dr. Helen Shih, Radiation Oncology Section Editor for CANCER, discuss the current treatment landscape for low-grade gliomas with a focus on the evolving role of isocitrate dehydrogenase (IDH) inhibitors. Drawing on findings from the INDIGO trial, they reflect on how recent evidence has informed ongoing discussions around the use of IDH inhibitors, alongside their perspectives on treatment planning and real-world clinical considerations. The conversation also emphasizes the importance of engaging patients in shared decision making throughout the course of care. 
Drs. Kumthekar and Shih invite investigators in neuro-oncology, radiation oncology, and related disciplines to consider submitting their research to CANCER. Their closing remarks highlight the journal’s global reach, supportive editorial staff, and connection to the mission of the American Cancer Society. 
Learn more about submitting your work to CANCER: https://acsjournals.onlinelibrary.wiley.com/journal/10970142/homepage/why-submit  
Original music by J.Gilman. 
Follow CANCER on social media: x.com/JournalCancer instagram.com/acsjournalcancer linkedin.com/company/acs-journals ]]></itunes:summary>
        <itunes:author>ACS Journal Cancer</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>935</itunes:duration>
                <itunes:episode>19</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Innovations in Colorectal Cancer Screening: Advances in Noninvasive Testing</title>
        <itunes:title>Innovations in Colorectal Cancer Screening: Advances in Noninvasive Testing</itunes:title>
        <link>https://cancerspeak.podbean.com/e/innovations-in-colorectal-cancer-screening-advances-in-noninvasive-testing/</link>
                    <comments>https://cancerspeak.podbean.com/e/innovations-in-colorectal-cancer-screening-advances-in-noninvasive-testing/#comments</comments>        <pubDate>Wed, 05 Nov 2025 11:02:09 -0400</pubDate>
        <guid isPermaLink="false">cancerspeak.podbean.com/ac5d3242-08da-385c-b0cc-8049f5683327</guid>
                                    <description><![CDATA[<p>Dr. Christopher Li, editor of the Cancer Prevention and Epidemiology sections for CANCER, speaks with Dr. William Grady of Fred Hutchinson Cancer Center about the latest innovations in noninvasive colorectal cancer screening. Their conversation draws on highlights from Dr. Grady’s latest commentary in CANCER’s Top Advances of the Year series, exploring how emerging stool- and blood-based testing approaches are improving early detection, patient participation, and screening accessibility.</p>
<p>Read the commentary “Top advances of the year: Noninvasive colorectal cancer screening tests” here: <a href='https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.70115'>https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.70115</a></p>
<p>Read more articles in CANCER’s Top Advances of the Year series: <a href='https://acsjournals.onlinelibrary.wiley.com/doi/toc/10.1002/(ISSN)1097-0142.top-advances-of-the-year'>https://acsjournals.onlinelibrary.wiley.com/doi/toc/10.1002/(ISSN)1097-0142.top-advances-of-the-year</a></p>
<p>Follow CANCER on social media:
<a href='https://x.com/JournalCancer'>x.com/JournalCancer</a>
<a href='https://www.instagram.com/acsjournalcancer'>instagram.com/acsjournalcancer</a>
<a href='https://www.linkedin.com/company/acs-journals/'>linkedin.com/company/acs-journals</a></p>
<p>Original music by J. Gilman.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Dr. Christopher Li, editor of the Cancer Prevention and Epidemiology sections for CANCER, speaks with Dr. William Grady of Fred Hutchinson Cancer Center about the latest innovations in noninvasive colorectal cancer screening. Their conversation draws on highlights from Dr. Grady’s latest commentary in CANCER’s Top Advances of the Year series, exploring how emerging stool- and blood-based testing approaches are improving early detection, patient participation, and screening accessibility.</p>
<p>Read the commentary “Top advances of the year: Noninvasive colorectal cancer screening tests” here: <a href='https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.70115'>https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.70115</a></p>
<p>Read more articles in CANCER’s Top Advances of the Year series: <a href='https://acsjournals.onlinelibrary.wiley.com/doi/toc/10.1002/(ISSN)1097-0142.top-advances-of-the-year'>https://acsjournals.onlinelibrary.wiley.com/doi/toc/10.1002/(ISSN)1097-0142.top-advances-of-the-year</a></p>
<p>Follow CANCER on social media:<br>
<a href='https://x.com/JournalCancer'>x.com/JournalCancer</a><br>
<a href='https://www.instagram.com/acsjournalcancer'>instagram.com/acsjournalcancer</a><br>
<a href='https://www.linkedin.com/company/acs-journals/'>linkedin.com/company/acs-journals</a></p>
<p>Original music by J. Gilman.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/uff6m3wrisecq6dv/CRC_testing_top_advances_v261wtj.mp3" length="33020052" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Dr. Christopher Li, editor of the Cancer Prevention and Epidemiology sections for CANCER, speaks with Dr. William Grady of Fred Hutchinson Cancer Center about the latest innovations in noninvasive colorectal cancer screening. Their conversation draws on highlights from Dr. Grady’s latest commentary in CANCER’s Top Advances of the Year series, exploring how emerging stool- and blood-based testing approaches are improving early detection, patient participation, and screening accessibility.
Read the commentary “Top advances of the year: Noninvasive colorectal cancer screening tests” here: https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.70115
Read more articles in CANCER’s Top Advances of the Year series: https://acsjournals.onlinelibrary.wiley.com/doi/toc/10.1002/(ISSN)1097-0142.top-advances-of-the-year
Follow CANCER on social media:x.com/JournalCancerinstagram.com/acsjournalcancerlinkedin.com/company/acs-journals
Original music by J. Gilman.]]></itunes:summary>
        <itunes:author>ACS Journal Cancer</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1375</itunes:duration>
                <itunes:episode>18</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>ASCO 2025 Recap: Advancing Cancer Research and Care</title>
        <itunes:title>ASCO 2025 Recap: Advancing Cancer Research and Care</itunes:title>
        <link>https://cancerspeak.podbean.com/e/asco-2025-recap-advancing-cancer-research-and-care/</link>
                    <comments>https://cancerspeak.podbean.com/e/asco-2025-recap-advancing-cancer-research-and-care/#comments</comments>        <pubDate>Wed, 13 Aug 2025 10:56:43 -0300</pubDate>
        <guid isPermaLink="false">cancerspeak.podbean.com/1df1ac11-f106-328e-a165-69825fbf54e0</guid>
                                    <description><![CDATA[<p>CANCER Editor-in-Chief Dr. Suresh Ramalingam is joined by Dr. Gil Morgan, Dr. Sandip Patel, and patient advocate Allison Rosen to reflect on key takeaways from the 2025 American Society of Clinical Oncology (ASCO) annual meeting. The discussion highlights notable clinical trials presented at the meeting, the emerging role of AI in the clinic and in research, and patient-centered perspectives on where the field is headed.

Interested in submitting your work to CANCER? Learn more about our submission benefits, such as Free Format Submission and Direct to CANCER, here: <a href='https://acsjournals.onlinelibrary.wiley.com/hub/journal/10970142/homepage/forauthors.html'>https://acsjournals.onlinelibrary.wiley.com/hub/journal/10970142/homepage/forauthors.html</a>

Follow CANCER on social media:
<a href='https://x.com/JournalCancer'>x.com/JournalCancer</a>
<a href='https://instagram.com/acsjournalcancer'>instagram.com/acsjournalcancer</a>
<a href='https://linkedin.com/company/acs-journals'>linkedin.com/company/acs-journals</a>

Original music by J. Gilman.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>CANCER Editor-in-Chief Dr. Suresh Ramalingam is joined by Dr. Gil Morgan, Dr. Sandip Patel, and patient advocate Allison Rosen to reflect on key takeaways from the 2025 American Society of Clinical Oncology (ASCO) annual meeting. The discussion highlights notable clinical trials presented at the meeting, the emerging role of AI in the clinic and in research, and patient-centered perspectives on where the field is headed.<br>
<br>
Interested in submitting your work to CANCER? Learn more about our submission benefits, such as Free Format Submission and Direct to CANCER, here: <a href='https://acsjournals.onlinelibrary.wiley.com/hub/journal/10970142/homepage/forauthors.html'>https://acsjournals.onlinelibrary.wiley.com/hub/journal/10970142/homepage/forauthors.html</a><br>
<br>
Follow CANCER on social media:<br>
<a href='https://x.com/JournalCancer'>x.com/JournalCancer</a><br>
<a href='https://instagram.com/acsjournalcancer'>instagram.com/acsjournalcancer</a><br>
<a href='https://linkedin.com/company/acs-journals'>linkedin.com/company/acs-journals</a><br>
<br>
Original music by J. Gilman.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/8w2y6722jgd3pih6/ASCO25_v2.mp3" length="33933265" type="audio/mpeg"/>
        <itunes:summary><![CDATA[CANCER Editor-in-Chief Dr. Suresh Ramalingam is joined by Dr. Gil Morgan, Dr. Sandip Patel, and patient advocate Allison Rosen to reflect on key takeaways from the 2025 American Society of Clinical Oncology (ASCO) annual meeting. The discussion highlights notable clinical trials presented at the meeting, the emerging role of AI in the clinic and in research, and patient-centered perspectives on where the field is headed.Interested in submitting your work to CANCER? Learn more about our submission benefits, such as Free Format Submission and Direct to CANCER, here: https://acsjournals.onlinelibrary.wiley.com/hub/journal/10970142/homepage/forauthors.htmlFollow CANCER on social media:x.com/JournalCancerinstagram.com/acsjournalcancerlinkedin.com/company/acs-journalsOriginal music by J. Gilman.]]></itunes:summary>
        <itunes:author>ACS Journal Cancer</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1413</itunes:duration>
                <itunes:episode>17</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>CancerSpeak Mini Episode 4: New Guideline for Peritoneal Mesothelioma Management</title>
        <itunes:title>CancerSpeak Mini Episode 4: New Guideline for Peritoneal Mesothelioma Management</itunes:title>
        <link>https://cancerspeak.podbean.com/e/cancerspeak-mini-episode-4-new-guideline-for-peritoneal-mesothelioma-management/</link>
                    <comments>https://cancerspeak.podbean.com/e/cancerspeak-mini-episode-4-new-guideline-for-peritoneal-mesothelioma-management/#comments</comments>        <pubDate>Wed, 25 Jun 2025 15:00:05 -0300</pubDate>
        <guid isPermaLink="false">cancerspeak.podbean.com/51dc7219-1bc5-3775-ac6a-d0ed0f370ce7</guid>
                                    <description><![CDATA[<p>Dr. Samuel Butensky and Dr. Elizabeth Godfrey briefly discuss the article “Consensus Guideline for the Management of Peritoneal Mesothelioma,” which introduces updated clinical guidance for this disease. This article is part of a series published jointly in Cancer and Annals of Surgical Oncology entitled “Consensus Guidelines for the Management of Peritoneal Surface Malignancies.”</p>
<p>🔗 Read the full article in Cancer: <a href='https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.35868'>https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.35868</a></p>
<p>📖 Explore all articles from the series: <a href='https://acsjournals.onlinelibrary.wiley.com/doi/toc/10.1002/(ISSN)1097-0142.PSM-consensus-guidelines'>https://acsjournals.onlinelibrary.wiley.com/doi/toc/10.1002/(ISSN)1097-0142.PSM-consensus-guidelines</a></p>
<p>Music by Ivymusic from Pixabay.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Dr. Samuel Butensky and Dr. Elizabeth Godfrey briefly discuss the article “Consensus Guideline for the Management of Peritoneal Mesothelioma,” which introduces updated clinical guidance for this disease. This article is part of a series published jointly in <em>Cancer</em> and <em>Annals of Surgical Oncology</em> entitled “Consensus Guidelines for the Management of Peritoneal Surface Malignancies.”</p>
<p>🔗 Read the full article in <em>Cancer</em>: <a href='https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.35868'>https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.35868</a></p>
<p>📖 Explore all articles from the series: <a href='https://acsjournals.onlinelibrary.wiley.com/doi/toc/10.1002/(ISSN)1097-0142.PSM-consensus-guidelines'>https://acsjournals.onlinelibrary.wiley.com/doi/toc/10.1002/(ISSN)1097-0142.PSM-consensus-guidelines</a></p>
<p>Music by Ivymusic from Pixabay.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/3c9ttajkfctgngh3/CNCR-24-1210R1_podcast_v1al0t8.mp3" length="4001461" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Dr. Samuel Butensky and Dr. Elizabeth Godfrey briefly discuss the article “Consensus Guideline for the Management of Peritoneal Mesothelioma,” which introduces updated clinical guidance for this disease. This article is part of a series published jointly in Cancer and Annals of Surgical Oncology entitled “Consensus Guidelines for the Management of Peritoneal Surface Malignancies.”
🔗 Read the full article in Cancer: https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.35868
📖 Explore all articles from the series: https://acsjournals.onlinelibrary.wiley.com/doi/toc/10.1002/(ISSN)1097-0142.PSM-consensus-guidelines
Music by Ivymusic from Pixabay.]]></itunes:summary>
        <itunes:author>ACS Journal Cancer</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>166</itunes:duration>
                <itunes:episode>16</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>CancerSpeak Mini Episode 3: Updated Approaches to Appendiceal Tumors With Peritoneal Involvement</title>
        <itunes:title>CancerSpeak Mini Episode 3: Updated Approaches to Appendiceal Tumors With Peritoneal Involvement</itunes:title>
        <link>https://cancerspeak.podbean.com/e/cancerspeak-mini-episode-3-updated-approaches-to-appendiceal-tumors-with-peritoneal-involvement/</link>
                    <comments>https://cancerspeak.podbean.com/e/cancerspeak-mini-episode-3-updated-approaches-to-appendiceal-tumors-with-peritoneal-involvement/#comments</comments>        <pubDate>Wed, 25 Jun 2025 14:58:58 -0300</pubDate>
        <guid isPermaLink="false">cancerspeak.podbean.com/e4dd0eb9-5d2f-3c72-a188-1ad7220ba7ed</guid>
                                    <description><![CDATA[<p>Dr. Elizabeth Godfrey is joined by Drs. Michael White and Mustafa Raoof to discuss “Consensus Guideline for the Management of Patients with Appendiceal Tumors, Part 2: Appendiceal Tumors With Peritoneal Involvement.” This article is part of a series published jointly in Cancer and Annals of Surgical Oncology entitled “Consensus Guidelines for the Management of Peritoneal Surface Malignancies.”</p>
<p>🔗 Read the full article in Cancer: <a href='https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.35874'>https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.35874</a></p>
<p>📖 Explore all articles from the series: <a href='https://acsjournals.onlinelibrary.wiley.com/doi/toc/10.1002/(ISSN)1097-0142.PSM-consensus-guidelines'>https://acsjournals.onlinelibrary.wiley.com/doi/toc/10.1002/(ISSN)1097-0142.PSM-consensus-guidelines</a></p>
<p>Music by Ivymusic from Pixabay.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Dr. Elizabeth Godfrey is joined by Drs. Michael White and Mustafa Raoof to discuss “Consensus Guideline for the Management of Patients with Appendiceal Tumors, Part 2: Appendiceal Tumors With Peritoneal Involvement.” This article is part of a series published jointly in <em>Cancer</em> and <em>Annals of Surgical Oncology</em> entitled “Consensus Guidelines for the Management of Peritoneal Surface Malignancies.”</p>
<p>🔗 Read the full article in <em>Cancer</em>: <a href='https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.35874'>https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.35874</a></p>
<p>📖 Explore all articles from the series: <a href='https://acsjournals.onlinelibrary.wiley.com/doi/toc/10.1002/(ISSN)1097-0142.PSM-consensus-guidelines'>https://acsjournals.onlinelibrary.wiley.com/doi/toc/10.1002/(ISSN)1097-0142.PSM-consensus-guidelines</a></p>
<p>Music by Ivymusic from Pixabay.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/8vjuymf2ukt232z8/CNCR-24-2182R1_-_Appendiceal_part_2_v189lh1.mp3" length="3964004" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Dr. Elizabeth Godfrey is joined by Drs. Michael White and Mustafa Raoof to discuss “Consensus Guideline for the Management of Patients with Appendiceal Tumors, Part 2: Appendiceal Tumors With Peritoneal Involvement.” This article is part of a series published jointly in Cancer and Annals of Surgical Oncology entitled “Consensus Guidelines for the Management of Peritoneal Surface Malignancies.”
🔗 Read the full article in Cancer: https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.35874
📖 Explore all articles from the series: https://acsjournals.onlinelibrary.wiley.com/doi/toc/10.1002/(ISSN)1097-0142.PSM-consensus-guidelines
Music by Ivymusic from Pixabay.]]></itunes:summary>
        <itunes:author>ACS Journal Cancer</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>164</itunes:duration>
                <itunes:episode>15</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>CancerSpeak Mini Episode 2: New Guidance for Appendiceal Tumors Without Peritoneal Involvement</title>
        <itunes:title>CancerSpeak Mini Episode 2: New Guidance for Appendiceal Tumors Without Peritoneal Involvement</itunes:title>
        <link>https://cancerspeak.podbean.com/e/cancerspeak-mini-episode-2-new-guidance-for-appendiceal-tumors-without-peritoneal-involvement/</link>
                    <comments>https://cancerspeak.podbean.com/e/cancerspeak-mini-episode-2-new-guidance-for-appendiceal-tumors-without-peritoneal-involvement/#comments</comments>        <pubDate>Wed, 25 Jun 2025 14:57:27 -0300</pubDate>
        <guid isPermaLink="false">cancerspeak.podbean.com/b7e83543-72c3-3fd0-8094-8ff77e89ef98</guid>
                                    <description><![CDATA[<p>Dr. Elizabeth Godfrey, lead author of “Consensus Guideline for the Management of Patients with Appendiceal Tumors, Part 1: Appendiceal Tumors Without Peritoneal Involvement,” is joined by Drs. Michael White and Mustafa Raoof to discuss the updated clinical approach to this disease. This article is part of a series published jointly in Cancer and Annals of Surgical Oncology entitled “Consensus Guidelines for the Management of Peritoneal Surface Malignancies.”</p>
<p>🔗 Read the full article in Cancer: <a href='https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.35867'>https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.35867</a></p>
<p>📖 Explore all articles from the series: <a href='https://acsjournals.onlinelibrary.wiley.com/doi/toc/10.1002/(ISSN)1097-0142.PSM-consensus-guidelines'>https://acsjournals.onlinelibrary.wiley.com/doi/toc/10.1002/(ISSN)1097-0142.PSM-consensus-guidelines</a></p>
<p>Music by Ivymusic from Pixabay.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Dr. Elizabeth Godfrey, lead author of “Consensus Guideline for the Management of Patients with Appendiceal Tumors, Part 1: Appendiceal Tumors Without Peritoneal Involvement,” is joined by Drs. Michael White and Mustafa Raoof to discuss the updated clinical approach to this disease. This article is part of a series published jointly in <em>Cancer</em> and <em>Annals of Surgical Oncology</em> entitled “Consensus Guidelines for the Management of Peritoneal Surface Malignancies.”</p>
<p>🔗 Read the full article in <em>Cancer</em>: <a href='https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.35867'>https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.35867</a></p>
<p>📖 Explore all articles from the series: <a href='https://acsjournals.onlinelibrary.wiley.com/doi/toc/10.1002/(ISSN)1097-0142.PSM-consensus-guidelines'>https://acsjournals.onlinelibrary.wiley.com/doi/toc/10.1002/(ISSN)1097-0142.PSM-consensus-guidelines</a></p>
<p>Music by Ivymusic from Pixabay.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/2kfhdsgn8v8sivi5/CNCR-24-1209R1_-_Appendiceal_part_1_v1642us.mp3" length="3947386" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Dr. Elizabeth Godfrey, lead author of “Consensus Guideline for the Management of Patients with Appendiceal Tumors, Part 1: Appendiceal Tumors Without Peritoneal Involvement,” is joined by Drs. Michael White and Mustafa Raoof to discuss the updated clinical approach to this disease. This article is part of a series published jointly in Cancer and Annals of Surgical Oncology entitled “Consensus Guidelines for the Management of Peritoneal Surface Malignancies.”
🔗 Read the full article in Cancer: https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.35867
📖 Explore all articles from the series: https://acsjournals.onlinelibrary.wiley.com/doi/toc/10.1002/(ISSN)1097-0142.PSM-consensus-guidelines
Music by Ivymusic from Pixabay.]]></itunes:summary>
        <itunes:author>ACS Journal Cancer</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>163</itunes:duration>
                <itunes:episode>14</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>CancerSpeak Mini Episode 1: Gastric Cancer With Peritoneal Metastases</title>
        <itunes:title>CancerSpeak Mini Episode 1: Gastric Cancer With Peritoneal Metastases</itunes:title>
        <link>https://cancerspeak.podbean.com/e/cancerspeak-mini-episode-1-gastric-cancer-with-peritoneal-metastases/</link>
                    <comments>https://cancerspeak.podbean.com/e/cancerspeak-mini-episode-1-gastric-cancer-with-peritoneal-metastases/#comments</comments>        <pubDate>Wed, 25 Jun 2025 14:53:58 -0300</pubDate>
        <guid isPermaLink="false">cancerspeak.podbean.com/6b97a2fa-cab3-3a4f-8f2d-e3af94fdeb05</guid>
                                    <description><![CDATA[<p>Dr. Samuel Butensky, lead author of “Consensus Guideline for the Management of Gastric Cancer with Synchronous Peritoneal Metastases,” is joined by Dr. Brian Badgwell and Dr. Maheswari Senthil to highlight key updates to the 2018 Chicago Consensus guideline and clinical pathway. This article is part of a series published jointly in Cancer and Annals of Surgical Oncology entitled “Consensus Guidelines for the Management of Peritoneal Surface Malignancies.”</p>
<p>🔗 Read the full article in Cancer: <a href='https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.35870'>https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.35870</a></p>
<p>📖 Explore all articles from the series: <a href='https://acsjournals.onlinelibrary.wiley.com/doi/toc/10.1002/(ISSN)1097-0142.PSM-consensus-guidelines'>https://acsjournals.onlinelibrary.wiley.com/doi/toc/10.1002/(ISSN)1097-0142.PSM-consensus-guidelines</a></p>
<p>Music by Ivymusic from Pixabay.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Dr. Samuel Butensky, lead author of “Consensus Guideline for the Management of Gastric Cancer with Synchronous Peritoneal Metastases,” is joined by Dr. Brian Badgwell and Dr. Maheswari Senthil to highlight key updates to the 2018 Chicago Consensus guideline and clinical pathway. This article is part of a series published jointly in <em>Cancer</em> and <em>Annals of Surgical Oncology</em> entitled “Consensus Guidelines for the Management of Peritoneal Surface Malignancies.”</p>
<p>🔗 Read the full article in <em>Cancer</em>: <a href='https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.35870'>https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.35870</a></p>
<p>📖 Explore all articles from the series: <a href='https://acsjournals.onlinelibrary.wiley.com/doi/toc/10.1002/(ISSN)1097-0142.PSM-consensus-guidelines'>https://acsjournals.onlinelibrary.wiley.com/doi/toc/10.1002/(ISSN)1097-0142.PSM-consensus-guidelines</a></p>
<p>Music by Ivymusic from Pixabay.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/h3q6egep9h6996bn/CNCR-24-1207R2_-_Gastric_PSM_audioaabjn.mp3" length="6403473" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Dr. Samuel Butensky, lead author of “Consensus Guideline for the Management of Gastric Cancer with Synchronous Peritoneal Metastases,” is joined by Dr. Brian Badgwell and Dr. Maheswari Senthil to highlight key updates to the 2018 Chicago Consensus guideline and clinical pathway. This article is part of a series published jointly in Cancer and Annals of Surgical Oncology entitled “Consensus Guidelines for the Management of Peritoneal Surface Malignancies.”
🔗 Read the full article in Cancer: https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.35870
📖 Explore all articles from the series: https://acsjournals.onlinelibrary.wiley.com/doi/toc/10.1002/(ISSN)1097-0142.PSM-consensus-guidelines
Music by Ivymusic from Pixabay.]]></itunes:summary>
        <itunes:author>ACS Journal Cancer</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>266</itunes:duration>
                <itunes:episode>13</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>The VOICES of Black Women Study: Expanding Representation in Cancer Research</title>
        <itunes:title>The VOICES of Black Women Study: Expanding Representation in Cancer Research</itunes:title>
        <link>https://cancerspeak.podbean.com/e/the-voices-of-black-women-study-expanding-representation-in-cancer-research/</link>
                    <comments>https://cancerspeak.podbean.com/e/the-voices-of-black-women-study-expanding-representation-in-cancer-research/#comments</comments>        <pubDate>Tue, 25 Mar 2025 11:02:12 -0300</pubDate>
        <guid isPermaLink="false">cancerspeak.podbean.com/45b40ed3-867d-3b9d-9039-116115c6329e</guid>
                                    <description><![CDATA[<p>Black women have long been underrepresented in large-scale cancer studies, leaving critical gaps in our understanding of the factors influencing cancer risk and outcomes. The VOICES of Black Women Study, launched by the American Cancer Society, is leading efforts to close these gaps by examining a range of health and social determinants to better understand their impact on cancer and other health conditions experienced by Black women. </p>
<p>In this episode of CancerSpeak, Cancer Disparities Research Section Editor Dr. Camille Ragin speaks with Dr. Lauren McCullough, one of the study’s principal investigators and the lead author of a newly published editorial in Cancer that explores the rationale behind the VOICES study and its potential to drive meaningful change in cancer prevention and care. </p>
<p>Read Dr. McCullough’s editorial in Cancer: <a href='https://bit.ly/VOICESofBlackWomenEditorial'>https://bit.ly/VOICESofBlackWomenEditorial</a>  </p>
<p>Learn more about the VOICES of Black Women study: <a href='https://bit.ly/VOICESofBlackWomenInfo'>https://bit.ly/VOICESofBlackWomenInfo</a> </p>
<p>Explore the American Cancer Society report “Cancer Statistics for African American and Black People, 2025” referenced in this episode: <a href='https://bit.ly/AAandBPStats2025'>https://bit.ly/AAandBPStats2025</a>  </p>
<p>Music by Ivymusic, obtained from Pixabay. 
 </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Black women have long been underrepresented in large-scale cancer studies, leaving critical gaps in our understanding of the factors influencing cancer risk and outcomes. The VOICES of Black Women Study, launched by the American Cancer Society, is leading efforts to close these gaps by examining a range of health and social determinants to better understand their impact on cancer and other health conditions experienced by Black women. </p>
<p>In this episode of CancerSpeak, <em>Cancer </em>Disparities Research Section Editor Dr. Camille Ragin speaks with Dr. Lauren McCullough, one of the study’s principal investigators and the lead author of a newly published editorial in <em>Cancer</em> that explores the rationale behind the VOICES study and its potential to drive meaningful change in cancer prevention and care. </p>
<p>Read Dr. McCullough’s editorial in <em>Cancer</em>: <a href='https://bit.ly/VOICESofBlackWomenEditorial'>https://bit.ly/VOICESofBlackWomenEditorial</a>  </p>
<p>Learn more about the VOICES of Black Women study: <a href='https://bit.ly/VOICESofBlackWomenInfo'>https://bit.ly/VOICESofBlackWomenInfo</a> </p>
<p>Explore the American Cancer Society report “Cancer Statistics for African American and Black People, 2025”<em> </em>referenced in this episode<em>:</em> <a href='https://bit.ly/AAandBPStats2025'>https://bit.ly/AAandBPStats2025</a>  </p>
<p>Music by Ivymusic, obtained from Pixabay. <br>
 </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/wex7ht6eudp555g2/VOICES_podcast_v19gn43.mp3" length="30452345" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Black women have long been underrepresented in large-scale cancer studies, leaving critical gaps in our understanding of the factors influencing cancer risk and outcomes. The VOICES of Black Women Study, launched by the American Cancer Society, is leading efforts to close these gaps by examining a range of health and social determinants to better understand their impact on cancer and other health conditions experienced by Black women. 
In this episode of CancerSpeak, Cancer Disparities Research Section Editor Dr. Camille Ragin speaks with Dr. Lauren McCullough, one of the study’s principal investigators and the lead author of a newly published editorial in Cancer that explores the rationale behind the VOICES study and its potential to drive meaningful change in cancer prevention and care. 
Read Dr. McCullough’s editorial in Cancer: https://bit.ly/VOICESofBlackWomenEditorial  
Learn more about the VOICES of Black Women study: https://bit.ly/VOICESofBlackWomenInfo 
Explore the American Cancer Society report “Cancer Statistics for African American and Black People, 2025” referenced in this episode: https://bit.ly/AAandBPStats2025  
Music by Ivymusic, obtained from Pixabay.  ]]></itunes:summary>
        <itunes:author>ACS Journal Cancer</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1268</itunes:duration>
                <itunes:episode>12</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>The Power of Social Capital: Tackling Gender Inequalities in Academic Medicine</title>
        <itunes:title>The Power of Social Capital: Tackling Gender Inequalities in Academic Medicine</itunes:title>
        <link>https://cancerspeak.podbean.com/e/the-power-of-social-capital-tackling-gender-inequalities-in-academic-medicine/</link>
                    <comments>https://cancerspeak.podbean.com/e/the-power-of-social-capital-tackling-gender-inequalities-in-academic-medicine/#comments</comments>        <pubDate>Thu, 06 Mar 2025 10:00:05 -0400</pubDate>
        <guid isPermaLink="false">cancerspeak.podbean.com/53df354d-6246-33fd-811a-f1ccf5e80ab3</guid>
                                    <description><![CDATA[<p>In this episode of CancerSpeak, host Dr. Ruth O’Regan, Deputy Editor and Breast Disease Section Editor of Cancer, is joined by Dr. Jennifer Grandis of the University of California San Francisco to discuss her team’s recent review article in Cancer on gender disparities in academic medicine. Tune in for a fascinating conversation between Dr. O’Regan and Dr. Grandis that explores how social capital and networking inequalities shape career advancement, the critical role of sponsorship, and strategies to create a more inclusive professional landscape.</p>
<p>Read Dr. Grandis’s article: <a href='https://bit.ly/SocialCapitalAndNetworking'>https://bit.ly/SocialCapitalAndNetworking</a> </p>
<p>Music by Ivymusic, obtained from Pixabay.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode of CancerSpeak, host Dr. Ruth O’Regan, Deputy Editor and Breast Disease Section Editor of <em>Cancer</em>, is joined by Dr. Jennifer Grandis of the University of California San Francisco to discuss her team’s recent review article in <em>Cancer</em> on gender disparities in academic medicine. Tune in for a fascinating conversation between Dr. O’Regan and Dr. Grandis that explores how social capital and networking inequalities shape career advancement, the critical role of sponsorship, and strategies to create a more inclusive professional landscape.</p>
<p>Read Dr. Grandis’s article: <a href='https://bit.ly/SocialCapitalAndNetworking'>https://bit.ly/SocialCapitalAndNetworking</a> </p>
<p>Music by Ivymusic, obtained from Pixabay.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/raa75398amb22kjt/Gender_disparities_podcast_v291oeh.mp3" length="34793914" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode of CancerSpeak, host Dr. Ruth O’Regan, Deputy Editor and Breast Disease Section Editor of Cancer, is joined by Dr. Jennifer Grandis of the University of California San Francisco to discuss her team’s recent review article in Cancer on gender disparities in academic medicine. Tune in for a fascinating conversation between Dr. O’Regan and Dr. Grandis that explores how social capital and networking inequalities shape career advancement, the critical role of sponsorship, and strategies to create a more inclusive professional landscape.
Read Dr. Grandis’s article: https://bit.ly/SocialCapitalAndNetworking 
Music by Ivymusic, obtained from Pixabay.]]></itunes:summary>
        <itunes:author>ACS Journal Cancer</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1449</itunes:duration>
                <itunes:episode>11</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>CHIP, mCAs, and Cancer Risk: What We’re Learning</title>
        <itunes:title>CHIP, mCAs, and Cancer Risk: What We’re Learning</itunes:title>
        <link>https://cancerspeak.podbean.com/e/chip-mcas-and-cancer-risk-what-we-re-learning/</link>
                    <comments>https://cancerspeak.podbean.com/e/chip-mcas-and-cancer-risk-what-we-re-learning/#comments</comments>        <pubDate>Thu, 21 Nov 2024 09:00:00 -0400</pubDate>
        <guid isPermaLink="false">cancerspeak.podbean.com/395db039-2605-368f-8802-8e060e40a81c</guid>
                                    <description><![CDATA[<p>CANCER Section Editor and Host Dr. Courtney DiNardo welcomes Dr. Pinkal Desai, Dr. Koichi Takahashi, and Ms. Nehali Shah to discuss new research on the impact of clonal hematopoiesis of indeterminate potential (CHIP) and mosaic chromosomal alterations (mCAs) on the risk and mortality of solid tumors like breast, lung, and colorectal cancer. Dr. Desai highlights findings from her recent study published in CANCER, while Dr. Takahashi and Ms. Shah share perspectives from their accompanying editorial. The episode explores the potential impact of these findings on clinical care and future research directions.</p>
<p>Read Dr. Desai’s article: <a href='https://bit.ly/CHIPandmCAsonSolidTumorRisk'>https://bit.ly/CHIPandmCAsonSolidTumorRisk</a></p>
<p>Read the editorial by Dr. Takahashi and Ms. Shah: <a href='https://bit.ly/CHIPandmCAsEditorial'>https://bit.ly/CHIPandmCAsEditorial</a></p>
<p>Music by Ivymusic, obtained from Pixabay.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>CANCER Section Editor and Host Dr. Courtney DiNardo welcomes Dr. Pinkal Desai, Dr. Koichi Takahashi, and Ms. Nehali Shah to discuss new research on the impact of clonal hematopoiesis of indeterminate potential (CHIP) and mosaic chromosomal alterations (mCAs) on the risk and mortality of solid tumors like breast, lung, and colorectal cancer. Dr. Desai highlights findings from her recent study published in CANCER, while Dr. Takahashi and Ms. Shah share perspectives from their accompanying editorial. The episode explores the potential impact of these findings on clinical care and future research directions.</p>
<p>Read Dr. Desai’s article: <a href='https://bit.ly/CHIPandmCAsonSolidTumorRisk'>https://bit.ly/CHIPandmCAsonSolidTumorRisk</a></p>
<p>Read the editorial by Dr. Takahashi and Ms. Shah: <a href='https://bit.ly/CHIPandmCAsEditorial'>https://bit.ly/CHIPandmCAsEditorial</a></p>
<p>Music by Ivymusic, obtained from Pixabay.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ryuqghsf63ykbrup/CHIP_and_MCA_podcast_v18emz7.mp3" length="30716807" type="audio/mpeg"/>
        <itunes:summary><![CDATA[CANCER Section Editor and Host Dr. Courtney DiNardo welcomes Dr. Pinkal Desai, Dr. Koichi Takahashi, and Ms. Nehali Shah to discuss new research on the impact of clonal hematopoiesis of indeterminate potential (CHIP) and mosaic chromosomal alterations (mCAs) on the risk and mortality of solid tumors like breast, lung, and colorectal cancer. Dr. Desai highlights findings from her recent study published in CANCER, while Dr. Takahashi and Ms. Shah share perspectives from their accompanying editorial. The episode explores the potential impact of these findings on clinical care and future research directions.
Read Dr. Desai’s article: https://bit.ly/CHIPandmCAsonSolidTumorRisk
Read the editorial by Dr. Takahashi and Ms. Shah: https://bit.ly/CHIPandmCAsEditorial
Music by Ivymusic, obtained from Pixabay.]]></itunes:summary>
        <itunes:author>ACS Journal Cancer</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1279</itunes:duration>
                <itunes:episode>10</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Key Highlights from ESMO 2024 – Shaping the Future of Clinical Oncology</title>
        <itunes:title>Key Highlights from ESMO 2024 – Shaping the Future of Clinical Oncology</itunes:title>
        <link>https://cancerspeak.podbean.com/e/key-highlights-from-esmo-2024-%e2%80%93-shaping-the-future-of-clinical-oncology/</link>
                    <comments>https://cancerspeak.podbean.com/e/key-highlights-from-esmo-2024-%e2%80%93-shaping-the-future-of-clinical-oncology/#comments</comments>        <pubDate>Wed, 06 Nov 2024 10:50:17 -0400</pubDate>
        <guid isPermaLink="false">cancerspeak.podbean.com/332c3e07-e0fc-3f21-a648-4b6271eceb20</guid>
                                    <description><![CDATA[<p>In this special edition of CancerSpeak, CANCER Editor-in-Chief Dr. Suresh Ramalingam is joined by Dr. Gil Morgan (Social Media Editor for CANCER), Dr. Jason Luke (Melanoma and Skin Section Editor for CANCER), and patient advocate Deborah Collyar to discuss key takeaways from the European Society for Medical Oncology (ESMO) 2024 Congress. From advances in melanoma and immunotherapy, to the role social media plays during clinical oncology meetings and in patient advocacy, this episode explores emerging developments that have the potential to impact clinical oncology practice and patient care.</p>
<p>Learn more about Free Format submission with CANCER: <a href='https://bit.ly/CANCERFreeFormatSubmission'>https://bit.ly/CANCERFreeFormatSubmission</a></p>
<p>Read an introductory editorial about Direct to CANCER: <a href='https://bit.ly/DirectToCANCER'>https://bit.ly/DirectToCANCER</a></p>
<p>Music by Ivymusic, obtained from Pixabay.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this special edition of CancerSpeak, CANCER Editor-in-Chief Dr. Suresh Ramalingam is joined by Dr. Gil Morgan (Social Media Editor for CANCER), Dr. Jason Luke (Melanoma and Skin Section Editor for CANCER), and patient advocate Deborah Collyar to discuss key takeaways from the European Society for Medical Oncology (ESMO) 2024 Congress. From advances in melanoma and immunotherapy, to the role social media plays during clinical oncology meetings and in patient advocacy, this episode explores emerging developments that have the potential to impact clinical oncology practice and patient care.</p>
<p>Learn more about Free Format submission with CANCER: <a href='https://bit.ly/CANCERFreeFormatSubmission'>https://bit.ly/CANCERFreeFormatSubmission</a></p>
<p>Read an introductory editorial about Direct to CANCER: <a href='https://bit.ly/DirectToCANCER'>https://bit.ly/DirectToCANCER</a></p>
<p>Music by Ivymusic, obtained from Pixabay.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/nwf9d6zbhfn7bzh9/ESMO_podcast_v29psup.mp3" length="36339537" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this special edition of CancerSpeak, CANCER Editor-in-Chief Dr. Suresh Ramalingam is joined by Dr. Gil Morgan (Social Media Editor for CANCER), Dr. Jason Luke (Melanoma and Skin Section Editor for CANCER), and patient advocate Deborah Collyar to discuss key takeaways from the European Society for Medical Oncology (ESMO) 2024 Congress. From advances in melanoma and immunotherapy, to the role social media plays during clinical oncology meetings and in patient advocacy, this episode explores emerging developments that have the potential to impact clinical oncology practice and patient care.
Learn more about Free Format submission with CANCER: https://bit.ly/CANCERFreeFormatSubmission
Read an introductory editorial about Direct to CANCER: https://bit.ly/DirectToCANCER
Music by Ivymusic, obtained from Pixabay.]]></itunes:summary>
        <itunes:author>ACS Journal Cancer</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1513</itunes:duration>
                <itunes:episode>9</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Top Advances in Cervical Cancer: A Year in Review</title>
        <itunes:title>Top Advances in Cervical Cancer: A Year in Review</itunes:title>
        <link>https://cancerspeak.podbean.com/e/top-advances-in-cervical-cancer-a-year-in-review/</link>
                    <comments>https://cancerspeak.podbean.com/e/top-advances-in-cervical-cancer-a-year-in-review/#comments</comments>        <pubDate>Wed, 14 Aug 2024 09:14:17 -0300</pubDate>
        <guid isPermaLink="false">cancerspeak.podbean.com/bc12562e-fdbc-3964-814e-f1d9a52ebea7</guid>
                                    <description><![CDATA[<p>In this episode of CancerSpeak, Dr. Linda R. Duska, lead author of the recent article "Top Advances of the Year: Cervical Cancer," joins host Dr. Akinyemi Ojesina and special guest Linda Ryan, a cervical cancer survivor and patient advocate, to discuss the latest breakthroughs in cervical cancer treatment. They explore the uniqueness of the SHAPE surgical de-escalation trial, the importance of increasing racial and geographical diversity in clinical trials, and key takeaways for patients with cervical cancer and their families.</p>
<p> </p>
<p>Read the article: <a href='https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.35334'>https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.35334</a></p>
<p> </p>
<p>Music by Ivymusic, obtained from Pixabay</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode of CancerSpeak, Dr. Linda R. Duska, lead author of the recent article "Top Advances of the Year: Cervical Cancer," joins host Dr. Akinyemi Ojesina and special guest Linda Ryan, a cervical cancer survivor and patient advocate, to discuss the latest breakthroughs in cervical cancer treatment. They explore the uniqueness of the SHAPE surgical de-escalation trial, the importance of increasing racial and geographical diversity in clinical trials, and key takeaways for patients with cervical cancer and their families.</p>
<p> </p>
<p>Read the article: <a href='https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.35334'>https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.35334</a></p>
<p> </p>
<p>Music by Ivymusic, obtained from Pixabay</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/eb93g88h29syryhx/TA_cervical_podcast_v1837cp.mp3" length="28736596" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode of CancerSpeak, Dr. Linda R. Duska, lead author of the recent article "Top Advances of the Year: Cervical Cancer," joins host Dr. Akinyemi Ojesina and special guest Linda Ryan, a cervical cancer survivor and patient advocate, to discuss the latest breakthroughs in cervical cancer treatment. They explore the uniqueness of the SHAPE surgical de-escalation trial, the importance of increasing racial and geographical diversity in clinical trials, and key takeaways for patients with cervical cancer and their families.
 
Read the article: https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.35334
 
Music by Ivymusic, obtained from Pixabay]]></itunes:summary>
        <itunes:author>ACS Journal Cancer</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1196</itunes:duration>
                <itunes:episode>8</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Cancer in LGBTQ+ populations: New insights on cancer risk factors and screening</title>
        <itunes:title>Cancer in LGBTQ+ populations: New insights on cancer risk factors and screening</itunes:title>
        <link>https://cancerspeak.podbean.com/e/cancer-in-lgbtq-populations-new-insights-on-cancer-risk-factors-and-screening/</link>
                    <comments>https://cancerspeak.podbean.com/e/cancer-in-lgbtq-populations-new-insights-on-cancer-risk-factors-and-screening/#comments</comments>        <pubDate>Mon, 24 Jun 2024 16:10:36 -0300</pubDate>
        <guid isPermaLink="false">cancerspeak.podbean.com/d68096b6-050a-3008-8143-cfadf3962ac8</guid>
                                    <description><![CDATA[<p>In this episode of CancerSpeak, host Tyler Kratzer MPH is joined by coauthors Jessica Star MA, MPH; Scout MA, PhD; and Monique Gary DO to discuss the groundbreaking findings from the American Cancer Society's latest report, "Cancer in People who Identify as Lesbian, Gay, Bisexual, Transgender, Queer, or Gender-nonconforming." This landmark study is the first to provide a comprehensive national analysis of cancer risk factors and screening within LGBTQ+ populations. Listen in as the investigators delve into the unique challenges and disparities faced by LGBTQ+ communities and explore critical steps needed to improve cancer prevention and care.</p>
<p>For the full text of the featured article, visit: <a href='https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.35355'>https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.35355</a></p>
<p>Learn more about Welcoming Spaces: <a href='https://cancer-network.org/welcoming-spaces/'>https://cancer-network.org/welcoming-spaces/</a></p>
<p>Music by Ivymusic from Pixabay</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode of CancerSpeak, host Tyler Kratzer MPH is joined by coauthors Jessica Star MA, MPH; Scout MA, PhD; and Monique Gary DO to discuss the groundbreaking findings from the American Cancer Society's latest report, "Cancer in People who Identify as Lesbian, Gay, Bisexual, Transgender, Queer, or Gender-nonconforming." This landmark study is the first to provide a comprehensive national analysis of cancer risk factors and screening within LGBTQ+ populations. Listen in as the investigators delve into the unique challenges and disparities faced by LGBTQ+ communities and explore critical steps needed to improve cancer prevention and care.</p>
<p>For the full text of the featured article, visit: <a href='https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.35355'>https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.35355</a></p>
<p>Learn more about Welcoming Spaces: <a href='https://cancer-network.org/welcoming-spaces/'>https://cancer-network.org/welcoming-spaces/</a></p>
<p>Music by Ivymusic from Pixabay</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/egtjaq46fs7429r5/LGBTQ_podcast_v25yjmu.mp3" length="31879738" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode of CancerSpeak, host Tyler Kratzer MPH is joined by coauthors Jessica Star MA, MPH; Scout MA, PhD; and Monique Gary DO to discuss the groundbreaking findings from the American Cancer Society's latest report, "Cancer in People who Identify as Lesbian, Gay, Bisexual, Transgender, Queer, or Gender-nonconforming." This landmark study is the first to provide a comprehensive national analysis of cancer risk factors and screening within LGBTQ+ populations. Listen in as the investigators delve into the unique challenges and disparities faced by LGBTQ+ communities and explore critical steps needed to improve cancer prevention and care.
For the full text of the featured article, visit: https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.35355
Learn more about Welcoming Spaces: https://cancer-network.org/welcoming-spaces/
Music by Ivymusic from Pixabay]]></itunes:summary>
        <itunes:author>ACS Journal Cancer</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1327</itunes:duration>
                <itunes:episode>7</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Top Advances of the Year in Ovarian Cancer with Dr. Linda Duska, Dr. Melissa Lumish, Dr. William Tew, and Annie Ellis</title>
        <itunes:title>Top Advances of the Year in Ovarian Cancer with Dr. Linda Duska, Dr. Melissa Lumish, Dr. William Tew, and Annie Ellis</itunes:title>
        <link>https://cancerspeak.podbean.com/e/top-advances-of-the-year-in-ovarian-cancer-with-dr-linda-duska-dr-melissa-lumish-dr-william-tew-and-annie-ellis/</link>
                    <comments>https://cancerspeak.podbean.com/e/top-advances-of-the-year-in-ovarian-cancer-with-dr-linda-duska-dr-melissa-lumish-dr-william-tew-and-annie-ellis/#comments</comments>        <pubDate>Tue, 30 Jan 2024 11:25:40 -0400</pubDate>
        <guid isPermaLink="false">cancerspeak.podbean.com/ab153a36-bab2-32ee-a394-ddb708c037dd</guid>
                                    <description><![CDATA[<p>In this CancerSpeak episode, CANCER Editorial Board Member Dr. Linda Duska is joined by Dr. Melissa Lumish and Dr. William Tew to discuss the latest advances in epithelial ovarian cancer research, including results demonstrating improved survival and outcomes of negative trials. Annie Ellis, a 19-year ovarian cancer survivor and research advocate, also joins to provide a patient perspective. </p>
<p>Access the article at <a href='https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.35135'>https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.35135</a></p>
<p>Music: Ivymusic from Pixabay</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this CancerSpeak episode, CANCER Editorial Board Member Dr. Linda Duska is joined by Dr. Melissa Lumish and Dr. William Tew to discuss the latest advances in epithelial ovarian cancer research, including results demonstrating improved survival and outcomes of negative trials. Annie Ellis, a 19-year ovarian cancer survivor and research advocate, also joins to provide a patient perspective. </p>
<p>Access the article at <a href='https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.35135'>https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.35135</a></p>
<p>Music: Ivymusic from Pixabay</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/s7yjdh/Ovarian_TA_Podcast_FINAL7xw62.mp3" length="35927791" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this CancerSpeak episode, CANCER Editorial Board Member Dr. Linda Duska is joined by Dr. Melissa Lumish and Dr. William Tew to discuss the latest advances in epithelial ovarian cancer research, including results demonstrating improved survival and outcomes of negative trials. Annie Ellis, a 19-year ovarian cancer survivor and research advocate, also joins to provide a patient perspective. 
Access the article at https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.35135
Music: Ivymusic from Pixabay]]></itunes:summary>
        <itunes:author>ACS Journal Cancer</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1496</itunes:duration>
                <itunes:episode>6</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Assessing the COVID-19 pandemic’s impact on cancer diagnosis with Dr. Serban Negoita and Dr. Ahmedin Jemal</title>
        <itunes:title>Assessing the COVID-19 pandemic’s impact on cancer diagnosis with Dr. Serban Negoita and Dr. Ahmedin Jemal</itunes:title>
        <link>https://cancerspeak.podbean.com/e/assessing-the-covid-19-pandemic-s-impact-on-cancer-diagnosis-with-dr-serban-negoita-and-dr-ahmedin-jemal/</link>
                    <comments>https://cancerspeak.podbean.com/e/assessing-the-covid-19-pandemic-s-impact-on-cancer-diagnosis-with-dr-serban-negoita-and-dr-ahmedin-jemal/#comments</comments>        <pubDate>Mon, 13 Nov 2023 10:49:18 -0400</pubDate>
        <guid isPermaLink="false">cancerspeak.podbean.com/e3047efc-d8df-350d-888c-7f18a89d4d56</guid>
                                    <description><![CDATA[<p>CANCER Editor-in-Chief Dr. Suresh Ramalingam is joined by Dr. Serban Negoita and Dr. Ahmedin Jemal to discuss part 2 of the latest Annual Report to the Nation on the Status of Cancer, which features the largest study to date on the COVID-19 pandemic’s impact on new cancer diagnoses in the United States.</p>
<p>Read the full report at: <a href='https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.35026'>https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.35026</a></p>
<p>Find cancer screening locations at: <a href='http://getscreened.cancer.org'>getscreened.cancer.org</a></p>
<p>Music: Ivymusic from Pixabay</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>CANCER Editor-in-Chief Dr. Suresh Ramalingam is joined by Dr. Serban Negoita and Dr. Ahmedin Jemal to discuss part 2 of the latest Annual Report to the Nation on the Status of Cancer, which features the largest study to date on the COVID-19 pandemic’s impact on new cancer diagnoses in the United States.</p>
<p>Read the full report at: <a href='https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.35026'>https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.35026</a></p>
<p>Find cancer screening locations at: <a href='http://getscreened.cancer.org'>getscreened.cancer.org</a></p>
<p>Music: Ivymusic from Pixabay</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/hfuypf/ARN_part_2_podcast_v180l07.mp3" length="22280585" type="audio/mpeg"/>
        <itunes:summary><![CDATA[CANCER Editor-in-Chief Dr. Suresh Ramalingam is joined by Dr. Serban Negoita and Dr. Ahmedin Jemal to discuss part 2 of the latest Annual Report to the Nation on the Status of Cancer, which features the largest study to date on the COVID-19 pandemic’s impact on new cancer diagnoses in the United States.
Read the full report at: https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.35026
Find cancer screening locations at: getscreened.cancer.org
Music: Ivymusic from Pixabay]]></itunes:summary>
        <itunes:author>ACS Journal Cancer</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>927</itunes:duration>
                <itunes:episode>5</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Episode 4, Part 4 of 4: Patient Navigation Perspectives from the National Navigation Roundtable</title>
        <itunes:title>Episode 4, Part 4 of 4: Patient Navigation Perspectives from the National Navigation Roundtable</itunes:title>
        <link>https://cancerspeak.podbean.com/e/patient-nav-and-cancer-care-pt-4/</link>
                    <comments>https://cancerspeak.podbean.com/e/patient-nav-and-cancer-care-pt-4/#comments</comments>        <pubDate>Thu, 17 Aug 2023 10:09:47 -0300</pubDate>
        <guid isPermaLink="false">cancerspeak.podbean.com/5cfc20fd-6c93-320c-99cd-fa66af3294c3</guid>
                                    <description><![CDATA[<p>In Part 4, the Roundtable members discuss the operational support needed to support distinct types of patient navigation delivery. We also hear their perspectives on the impact of COVID-19 on cancer care and the roles that patient navigators played during the height of the pandemic.</p>
<p>Read "A Decade Later: The State of Patient Navigation in Cancer” at <a href='https://acsjournals.onlinelibrary.wiley.com/toc/10970142/2022/128/S13'>https://acsjournals.onlinelibrary.wiley.com/toc/10970142/2022/128/S13</a>. </p>
<p>Music by Ivymusic from Pixabay.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In Part 4, the Roundtable members discuss the operational support needed to support distinct types of patient navigation delivery. We also hear their perspectives on the impact of COVID-19 on cancer care and the roles that patient navigators played during the height of the pandemic.</p>
<p>Read "A Decade Later: The State of Patient Navigation in Cancer” at <a href='https://acsjournals.onlinelibrary.wiley.com/toc/10970142/2022/128/S13'>https://acsjournals.onlinelibrary.wiley.com/toc/10970142/2022/128/S13</a>. </p>
<p>Music by Ivymusic from Pixabay.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/dscnji/Podcast_1_part_4_v1ae9gm.mp3" length="22165331" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In Part 4, the Roundtable members discuss the operational support needed to support distinct types of patient navigation delivery. We also hear their perspectives on the impact of COVID-19 on cancer care and the roles that patient navigators played during the height of the pandemic.
Read "A Decade Later: The State of Patient Navigation in Cancer” at https://acsjournals.onlinelibrary.wiley.com/toc/10970142/2022/128/S13. 
Music by Ivymusic from Pixabay.]]></itunes:summary>
        <itunes:author>ACS Journal Cancer</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>923</itunes:duration>
                <itunes:episode>4</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Episode 3, Part 3 of 4: Patient Navigation Perspectives from the National Navigation Roundtable</title>
        <itunes:title>Episode 3, Part 3 of 4: Patient Navigation Perspectives from the National Navigation Roundtable</itunes:title>
        <link>https://cancerspeak.podbean.com/e/patient-nav-and-cancer-care-pt-3/</link>
                    <comments>https://cancerspeak.podbean.com/e/patient-nav-and-cancer-care-pt-3/#comments</comments>        <pubDate>Wed, 16 Aug 2023 18:00:23 -0300</pubDate>
        <guid isPermaLink="false">cancerspeak.podbean.com/b13f4eb9-e3ac-379a-a3a4-252ef5fd9735</guid>
                                    <description><![CDATA[<p>In Part 3, the Roundtable members examine the most pressing questions in patient navigation. Do all patients have access to patient navigation services? Why did job postings for patient navigators triple between 2010 and 2015?</p>
<p>Read "A Decade Later: The State of Patient Navigation in Cancer” at <a href='https://acsjournals.onlinelibrary.wiley.com/toc/10970142/2022/128/S13'>https://acsjournals.onlinelibrary.wiley.com/toc/10970142/2022/128/S13</a>. </p>
<p>Music by Ivymusic from Pixabay.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In Part 3, the Roundtable members examine the most pressing questions in patient navigation. Do all patients have access to patient navigation services? Why did job postings for patient navigators triple between 2010 and 2015?</p>
<p>Read "A Decade Later: The State of Patient Navigation in Cancer” at <a href='https://acsjournals.onlinelibrary.wiley.com/toc/10970142/2022/128/S13'>https://acsjournals.onlinelibrary.wiley.com/toc/10970142/2022/128/S13</a>. </p>
<p>Music by Ivymusic from Pixabay.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/q7harn/Podcast_1_part_3_v18r2r3.mp3" length="22427898" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In Part 3, the Roundtable members examine the most pressing questions in patient navigation. Do all patients have access to patient navigation services? Why did job postings for patient navigators triple between 2010 and 2015?
Read "A Decade Later: The State of Patient Navigation in Cancer” at https://acsjournals.onlinelibrary.wiley.com/toc/10970142/2022/128/S13. 
Music by Ivymusic from Pixabay.]]></itunes:summary>
        <itunes:author>ACS Journal Cancer</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>934</itunes:duration>
                <itunes:episode>3</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Episode 2, Part 2 of 4: Patient Navigation Perspectives from the National Navigation Roundtable</title>
        <itunes:title>Episode 2, Part 2 of 4: Patient Navigation Perspectives from the National Navigation Roundtable</itunes:title>
        <link>https://cancerspeak.podbean.com/e/patient-nav-and-cancer-care-pt-2/</link>
                    <comments>https://cancerspeak.podbean.com/e/patient-nav-and-cancer-care-pt-2/#comments</comments>        <pubDate>Wed, 16 Aug 2023 17:55:56 -0300</pubDate>
        <guid isPermaLink="false">cancerspeak.podbean.com/f665acd4-abfa-3c96-82dd-89ca288d9b60</guid>
                                    <description><![CDATA[<p>In Part 2, the Roundtable members unpack the when, why, and how behind the start of patient navigation as well as current efforts to ensure the sustainability of patient navigation delivery.</p>
<p>Read "A Decade Later: The State of Patient Navigation in Cancer” at <a href='https://acsjournals.onlinelibrary.wiley.com/toc/10970142/2022/128/S13'>https://acsjournals.onlinelibrary.wiley.com/toc/10970142/2022/128/S13</a>. </p>
<p>Music by Ivymusic from Pixabay.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In Part 2, the Roundtable members unpack the when, why, and how behind the start of patient navigation as well as current efforts to ensure the sustainability of patient navigation delivery.</p>
<p>Read "A Decade Later: The State of Patient Navigation in Cancer” at <a href='https://acsjournals.onlinelibrary.wiley.com/toc/10970142/2022/128/S13'>https://acsjournals.onlinelibrary.wiley.com/toc/10970142/2022/128/S13</a>. </p>
<p>Music by Ivymusic from Pixabay.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/kqhu2z/Podcast_1_part_2_v29jeow.mp3" length="19679139" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In Part 2, the Roundtable members unpack the when, why, and how behind the start of patient navigation as well as current efforts to ensure the sustainability of patient navigation delivery.
Read "A Decade Later: The State of Patient Navigation in Cancer” at https://acsjournals.onlinelibrary.wiley.com/toc/10970142/2022/128/S13. 
Music by Ivymusic from Pixabay.]]></itunes:summary>
        <itunes:author>ACS Journal Cancer</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>819</itunes:duration>
                <itunes:episode>2</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Episode 1, Part 1 of 4: Patient Navigation Perspectives from the National Navigation Roundtable</title>
        <itunes:title>Episode 1, Part 1 of 4: Patient Navigation Perspectives from the National Navigation Roundtable</itunes:title>
        <link>https://cancerspeak.podbean.com/e/patient-nav-and-cancer-care-pt-1/</link>
                    <comments>https://cancerspeak.podbean.com/e/patient-nav-and-cancer-care-pt-1/#comments</comments>        <pubDate>Wed, 16 Aug 2023 16:21:12 -0300</pubDate>
        <guid isPermaLink="false">cancerspeak.podbean.com/11de03ce-e167-3678-b6c1-507706e10712</guid>
                                    <description><![CDATA[<p>CancerSpeak celebrates its launch with a special 4-part series featuring a conversation between members of the National Navigation Roundtable on patient navigation in cancer care.</p>
<p>Read "A Decade Later: The State of Patient Navigation in Cancer” at <a href='https://acsjournals.onlinelibrary.wiley.com/toc/10970142/2022/128/S13'>https://acsjournals.onlinelibrary.wiley.com/toc/10970142/2022/128/S13</a>. </p>
<p>Music by Ivymusic from Pixabay.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>CancerSpeak celebrates its launch with a special 4-part series featuring a conversation between members of the National Navigation Roundtable on patient navigation in cancer care.</p>
<p>Read "A Decade Later: The State of Patient Navigation in Cancer” at <a href='https://acsjournals.onlinelibrary.wiley.com/toc/10970142/2022/128/S13'>https://acsjournals.onlinelibrary.wiley.com/toc/10970142/2022/128/S13</a>. </p>
<p>Music by Ivymusic from Pixabay.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9cepmr/Podcast_1_part_1_v387kxm.mp3" length="23021266" type="audio/mpeg"/>
        <itunes:summary><![CDATA[CancerSpeak celebrates its launch with a special 4-part series featuring a conversation between members of the National Navigation Roundtable on patient navigation in cancer care.
Read "A Decade Later: The State of Patient Navigation in Cancer” at https://acsjournals.onlinelibrary.wiley.com/toc/10970142/2022/128/S13. 
Music by Ivymusic from Pixabay.]]></itunes:summary>
        <itunes:author>ACS Journal Cancer</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>958</itunes:duration>
                <itunes:episode>1</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <itunes:image href="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog14027812/CancerSpeak_logo_1__qqnptx.png" />    </item>
</channel>
</rss>
